FDA provides new guidance on conducting clinical trials with decentralised elements
Clinical studies have traditionally required participants to come to [...]
Rare Conversations podcast: the future of the rare disease landscape with Simon Estcourt
In this podcast, the first in our Rare Conversations [...]
How to get an EMA marketing authorisation
Obtaining marketing authorisation in Europe can be a complex [...]
Getting an EU marketing authorisation for orphan drugs
Thanks to its large population and well-established healthcare system, [...]
Revised Declaration of Helsinki adopted by the global medical community
The principles of Good Clinical Practice (GCP) are derived [...]
CDER releases annual ‘Accelerating Rare Disease Cures (ARC) Program’ report for 2024
The FDA’s Center For Drug Evaluation and Research (CDER) [...]
The role of pharmacovigilance in oncology drug trials
Some of our experts recently penned a thought-provoking article [...]
New Board members welcomed to TMC
Last week marked TMC's first Board meeting since our [...]
The FDA’s Project Optimus Initiative ~ expediting life-saving drugs to market without compromising on safety!
The Food and Drug Administration's (FDA) Project Optimus initiative, [...]
TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team
Hampshire, UK — 03 June 2024 TMC Pharma Services Ltd., [...]